What does Biogenosis do?
BIOGENOSIS specializes in biotechnological research and development, focusing on innovative solutions for healthcare and agriculture. The company aims to enhance the efficiency of biological processes through advanced genetic engineering techniques. BIOGENOSIS is committed to sustainability and improving quality of life through its products and services.
Juridical situation
Company number
Founding date
EUID number
Type of enterprise
Location
Juridical form
- Activities
-
No results found
- Signals
-
Reporting lossesReporting losses € -6K
The company reported a loss in the latest financial year.
Negative EBITDANegative EBITDA € -6KEBITDA is negative: operating activities are loss-making.
Strong equityStrong equity € 13.00MStrong equity provides a buffer against setbacks.
Low riskLow risk 79.3%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 5.18A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 79KPositive operating cash flow in the latest financial year.
- Shareholders
- Svr Invest 13,01%, Saffelberg Investments 11,28%, Ousia 1,66%
- Investments
- Imcyse 35,51%
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2021
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2020
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
-4K
|
€
-2K
|
€
-13K
|
€
-2K
|
|
|
€
-6K
|
€
-3K
|
€
-15K
|
€
-3K
|
|
|
€
79K
|
€
-3K
|
€
-18K
|
€
-11K
|
|
|
€
13.00M
|
€
12.93M
|
€
12.93M
|
€
7.33M
|
|
|
79.26%
|
99.68%
|
99.71%
|
94.05%
|
|
|
€
3.40M
|
€
41K
|
€
37K
|
€
463K
|
|
|
€
20K
|
€
28K
|
€
28K
|
€
403K
|
Publications 9
All publications- Statuts (Traduction, Coordination, Autres Modifications, ) - Capital, Actions 15/03/2021
- Statuts (Traduction, Coordination, Autres Modifications, ) - Capital, Actions 12/02/2021
- Capital, Actions 01/08/2019
- Siege Social - Capital, Actions - Demissions, Nominations 01/08/2019
- Me. - Comptes Annuels 31.12.2015, App 14.06.2016, Dpt 20.06.2016 16201-0128-013 27/06/2016
Frequently asked questions
Answers to the most common questions about Biogenosis, based on official government data and the filed annual accounts.
What is the VAT number of Biogenosis?
The VAT number of Biogenosis is BE0500.705.585.
When was Biogenosis established?
Biogenosis was founded in 09-11-2012.
What is the official address of Biogenosis?
The official address of Biogenosis is Rue Henri-Maus 78 Liège 4000.
What is the legal form of Biogenosis?
The juridical form of Biogenosis is Public limited company (NV/SA).
What is the legal situation of Biogenosis?
The legal situation of Biogenosis is Normal situation.
What is the annual revenue of Biogenosis?
The annual revenue of Biogenosis is €0.
What does Biogenosis do?
BIOGENOSIS specializes in biotechnological research and development, focusing on innovative solutions for healthcare and agriculture. The company aims to enhance the efficiency of biological processes through advanced genetic engineering techniques. BIOGENOSIS is committed to sustainability and improving quality of life through its products and services.
Where can I find Biogenosis?
Biogenosis is located at Rue Henri-Maus 78 Liège 4000 in Liège (4000).
Is Biogenosis a reliable company?
Biogenosis is a registered Rechtspersoon with company number 0500.705.585 and can be verified through the official CBE database.
What is the credit limit of Biogenosis?
The estimated credit limit of Biogenosis is €633,982.
Is Biogenosis still active?
Biogenosis currently has the status "Normal situation" and is actief.